Faculty

Institution

Unit

Venue

Matthew M. Gubin

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Immunology

Matthew M. Gubin is currently serving as an Immunology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Matthew M. Gubin

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

immunology immune responses cancer immunotherapy immunotherapy cancer research tumor biology oncology cell biology tumor microenvironment systems biology cellular therapy cancer cells cancer biology gene expression rna-binding protein hur oncogenes immune checkpoint inhibitors medicinal research cancer immunosurveillance cell research tumor targeting adaptive immune system molecular cancer cancer discovery rna biology tumor suppressors medicine clinical immunology system immunology cytokines immune dysregulation cell transplantation cancer treatment cancer care molecular immunology immunoediting antigen processing neoantigen cancer vaccines posttranscriptional gene regulation cellular physiology protein science molecular regulation transcription regulation vaccine efficacy immunosuppression cancer immunoediting dendritic cells cell metabolism molecular metabolism brain tumor research clinical investigation antiviral research metabolic regulation cellular biology biological microenvironments cell regulation anti-cancer agents tumor heterogeneity personalized treatments innate immune system colorectal cancer immunopathology therapy resistance graft survival myeloid neoplasia cancer progression metabolic competition component phases mhc-ii neoantigens tumor myeloid landscape tumor neoantigens personalized cancer immunotherapy abscopal responses immunotherapy responses immunotherapy success lymphoid compartment gene therapy metastasis pathogenesis autoimmune diseases translational research infectious diseases autoimmunity pathology translational medicine clinical proteomics reproductive immunology allergy molecular diagnostics jama oncology bioinformatics nucleic acids leukemia functional genomics medical virology surgical pathology cancer letter immunity (medicine) carcinogenesis transcriptome biomedical informatics radiation oncology histopathology molecular biology experimental medicine molecular medicine

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2812: Bhlhe40 Shapes Distinct T Cell Reponses to Anti Pd1 and Anti Ctla4 Immune Checkpoint Therapy. Cancer Research (2026)

immunologycellular immune responsesimmune checkpoint inhibitorsimmune responsescellular therapyimmunotherapy

AI-Powered Immune Cell Knowledge Graph (Ickg) With Granular Immune Contexts Enables Immune Program Interpretation. npj Artificial Intelligence (2026)

immunologyimmunological biomarkersimmunological computingbiomedical informaticsgranular immune contextsimmune program interpretationsystems biologycell researchartificial immune systemsystem immunologyadaptive immune systemimmune responsesimmunity (medicine)immunotherapy

Antigen Presentation Requirements for Effective Cdc1-Based Cancer Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2026)

immunologyimmune checkpoint inhibitorsantigen presentation requirementscancer immunotherapycancer cellsimmunotherapy

Immune Microenvironment and Strategy of Immunotherapy in Acral Melanoma. Immunological Medicine (2026)

immunologymelanomacancer immunotherapyimmune responsesimmunomodulationcellular therapytherapeutic vaccinesimmunotherapy

Radionuclide-Stimulated Dynamic Therapy Induces Complementary Immunogenic Necroptosis and Apoptosis Cancer Cell Death Pathways. Communications Biology (2026)

immunologytumor microenvironmentcell deathpharmacologyradiation oncologytumor biologycancer researchmolecular cancertherapeutic targetscancer immunotherapyoncologymedicinal researchcancer cellscancer letterjama oncologycellular therapyimmunotherapy

Spatial Immune Hubs Defined by Conserved Activated Dendritic Cells Are Remodeled by Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2026)

immunologyimmune mediatorsdendritic cellscellular immune responsesimmunologic mechanismssystems biologycell researchadaptive immune systemspatial immune hubsimmune responsesimmunomodulationtumor microenvironmentimmunity (medicine)cellular therapyimmunotherapycell biology

767 Type 1 Conventional Dendritic Cell Therapy Coordinates Tumor Control in Murine Melanoma. Regular and Young Investigator Award Abstracts (2025)

immunologymelanomamurine melanomacancer immunosurveillancecancer immunotherapycellular therapytype 1cancer cellstumor controltumor biologyimmunotherapycell biology

Abstract B040: Literature-Scaled Immunological Gene Set Annotation Using AI-Powered Immune Cell Knowledge Graph (Ickg). Clinical Cancer Research (2025)

immunologyimmunological computingimmunological biomarkersbiomedical informaticsomicsknowledge graphstranslational bioinformaticssystems biologycell researchliterature-scaled immunological genesystem immunologycellular therapyimmune responsesknowledge discoveryimmunity (medicine)molecular informaticsabstract b040

Bhlhe40 Governs T Cell Effector Differentiation With Distinct Requirements in Cd4 and Cd8 T Cells for Anti-Pd-1 and Anti-Ctla-4 Efficacy. bioRxiv (Cold Spring Harbor Laboratory) (2025)

immunologycellular immune responsescell researchimmune responseslymphocyte developmentimmunotherapycell biology

Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade. bioRxiv (Cold Spring Harbor Laboratory) (2025)

immunologycell deathcheckpoint blockadecellular immune responsesimmune checkpoint inhibitorscell researchcancer immunotherapyimmune responsescancer cellsimmunomodulationcellular therapyimmunotherapycell biology

1
2
3
4
5
6
7
10 / page

Matthew M. Gubin

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Immunology

Matthew M. Gubin is currently serving as an Immunology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Matthew M. Gubin

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2812: Bhlhe40 Shapes Distinct T Cell Reponses to Anti Pd1 and Anti Ctla4 Immune Checkpoint Therapy. Cancer Research (2026)

immunologycellular immune responsesimmune checkpoint inhibitorsimmune responsescellular therapyimmunotherapy

AI-Powered Immune Cell Knowledge Graph (Ickg) With Granular Immune Contexts Enables Immune Program Interpretation. npj Artificial Intelligence (2026)

Antigen Presentation Requirements for Effective Cdc1-Based Cancer Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2026)

immunologyimmune checkpoint inhibitorsantigen presentation requirementscancer immunotherapycancer cellsimmunotherapy

Immune Microenvironment and Strategy of Immunotherapy in Acral Melanoma. Immunological Medicine (2026)

immunologymelanomacancer immunotherapyimmune responsesimmunomodulationcellular therapytherapeutic vaccinesimmunotherapy

Radionuclide-Stimulated Dynamic Therapy Induces Complementary Immunogenic Necroptosis and Apoptosis Cancer Cell Death Pathways. Communications Biology (2026)

Spatial Immune Hubs Defined by Conserved Activated Dendritic Cells Are Remodeled by Immunotherapy. bioRxiv (Cold Spring Harbor Laboratory) (2026)

767 Type 1 Conventional Dendritic Cell Therapy Coordinates Tumor Control in Murine Melanoma. Regular and Young Investigator Award Abstracts (2025)

immunologymelanomamurine melanomacancer immunosurveillancecancer immunotherapycellular therapytype 1cancer cellstumor controltumor biologyimmunotherapycell biology

Abstract B040: Literature-Scaled Immunological Gene Set Annotation Using AI-Powered Immune Cell Knowledge Graph (Ickg). Clinical Cancer Research (2025)

Bhlhe40 Governs T Cell Effector Differentiation With Distinct Requirements in Cd4 and Cd8 T Cells for Anti-Pd-1 and Anti-Ctla-4 Efficacy. bioRxiv (Cold Spring Harbor Laboratory) (2025)

immunologycellular immune responsescell researchimmune responseslymphocyte developmentimmunotherapycell biology

Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade. bioRxiv (Cold Spring Harbor Laboratory) (2025)

1
2
3
4
5
6
7
10 / page